Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Plenary Session 3: Epigenetic Regulators as Therapeutic Targets

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Plenary Session 3: Epigenetic Regulators as Therapeutic Targets
Working together to identify new epigenetic targets for cancer
Chas Bountra
University of Oxford, Oxford, United Kingdom
from 2013 Molecular Targets and Cancer Therapeutics conference on October 21, 2013 8:00 AM-10:00 AM
Plenary Session 3: Epigenetic Regulators as Therapeutic Targets
  •  
  • Permission not
    granted for presentation
  •  
  •  
Targeting enhancers in cancers
James E. Bradner
Dana-Farber Cancer Inst., Boston, MA, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 21, 2013 8:00 AM-10:00 AM
Plenary Session 3: Epigenetic Regulators as Therapeutic Targets
  •  
  • Permission not
    granted for presentation
  •  
  •  
Designing p300/CBP histone acetyltransferase inhibitors for cancer
Philip A. Cole
Johns Hopkins Univ. School of Medicine, Baltimore, MD, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 21, 2013 8:00 AM-10:00 AM
Plenary Session 3: Epigenetic Regulators as Therapeutic Targets
Protein methyltransferase inhibitors as personalized cancer therapeutics
Robert A. Copeland
Epizyme, Inc., Cambridge, MA, United States
from 2013 Molecular Targets and Cancer Therapeutics conference on October 21, 2013 8:00 AM-10:00 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4